NCT01008683

Antibody Production Following H1N1 Influenza Vaccination After Stem Cell and Heart Transplantation

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 300 (estimated)
• Sponsor: Hadassah Medical Organization · Academic / Other
• Sex: All
• Age: 80 Years
• Healthy volunteers: Not accepted

Summary

Stem cell and and heart transplant patients will receive pandemic H1N1 influenza vaccination according to the clinical guidelines. In these patients the investigators will measure the specific antibody production.

Detailed description

Stem cell and and heart transplant patients will receive pandemic H1N1 influenza vaccination according to the clinical guidelines. Two doses will be given, in 3-week interval. In these patients we will measure the specific antibody production. Blood sample 5 ml will be drawn before the first vaccine, before the second, and 3-4 weeks after the 2nd dose.

Conditions

• H1N1 Influenza

Timeline

• Start date: 2009-11-01
• Primary completion: 2010-04-01
• Completion: 2010-07-01
• First posted: 2009-11-06
• Last updated: 2009-11-06

Locations

1 site across 1 country: Israel